Samsung Biologics Signs Contract with Pfizer for 922.7 Billion KRW Contract Manufacturing
Samsung Biologics announced on the 4th that it has signed a contract with Pfizer for contract manufacturing of pharmaceuticals worth 922.7 billion KRW.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- Businessman Sentenced to 3 Years for Embezzling 6.6 Billion Won to a 'Virtual Shaman'
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
This amount corresponds to 30.74% of recent sales, and the contract period is from the 30th of last month until December 31, 2029.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
